.svg){kind=small}
Dec-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of Illinois, Remedi has shown a consistent presence across multiple categories. In the Capsules category, the brand has maintained a relatively stable ranking, fluctuating slightly from 6th in September to 7th by December. This indicates a steady performance, with a notable sales increase in December. In the Concentrates category, Remedi's performance is more dynamic, improving from 18th place in September to 14th by December, suggesting a strong upward trend in consumer interest and sales. Meanwhile, in the Tincture & Sublingual category, Remedi has maintained a top position, holding steady at 3rd place for the last two months of the year, highlighting its strong foothold in this segment.
In Massachusetts, Remedi's performance in the Concentrates category has been more variable. The brand improved its ranking from 19th in September to 16th in October, but then saw a decline, falling to 25th in both November and December. This drop out of the top 20 could be a cause for concern, indicating potential challenges in maintaining market share in this category. Despite this volatility, the sales figures show some resilience, with a slight recovery in December. Such fluctuations highlight the competitive nature of the Massachusetts market and the need for strategic adjustments to regain higher rankings.
Competitive Landscape
In the competitive landscape of concentrates in Illinois, Remedi has shown a notable upward trajectory in its ranking from September to December 2024, moving from 18th to 14th place. This improvement is significant, especially when compared to competitors like Avexia, which remained relatively stable around the 17th position, and Amber, which fluctuated but ended at 15th. Despite Shelby County Community Services maintaining a stronger position, consistently ranking around 11th to 13th, Remedi's sales growth has been impressive, particularly in December, where it saw a substantial increase, closing the gap with higher-ranked brands. Meanwhile, nuEra has been a formidable competitor, consistently ranking higher, yet Remedi's strategic improvements in sales and ranking indicate a positive trend that could potentially challenge nuEra's position in the coming months.
Notable Products
In December 2024, the top-performing product from Remedi was the Indica Relief RSO Syringe (0.5g), which climbed to the number one rank with impressive sales of 4063 units. The Indica Rest RSO Dropper (0.5g) followed closely, dropping to the second position from its previous consistent first-place ranking. The Indica Rest RSO Syringe (0.5g) maintained its steady third-place rank across the months. The CBD/THC 1:5 Rest Tincture (20mg CBD, 100mg THC, 30ml) secured the fourth position, showing a slight improvement from its November rank. Notably, the OG Kush Breath RSO (1g) made its first appearance in the rankings at fifth place in December.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
